Harmony Biosciences develops therapies for rare neurological disorders, with WAKIX addressing excessive sleepiness in ...
Tirzepatide leads near-term, Retatrutide targets Class III, Foundayo expands maintenance—see 2030 sales & $1,300 PT.
For 41 years, members of the Lake of the Woods Kenora Lions Club have been walking to help provide Dog Guides for Canadians ...
The pharmaceutical company is cutting thousands of jobs as it restructures amid pressure from antitrust allegations in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results